SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003885
Filing Date
2024-01-08
Accepted
2024-01-08 07:28:34
Documents
73
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d103829d8k.htm   iXBRL 8-K 24682
2 EX-99.1 d103829dex991.htm EX-99.1 64564
6 GRAPHIC g103829ex99_1s10g1.jpg GRAPHIC 86805
7 GRAPHIC g103829ex99_1s11g1.jpg GRAPHIC 83795
8 GRAPHIC g103829ex99_1s12g1.jpg GRAPHIC 79307
9 GRAPHIC g103829ex99_1s13g1.jpg GRAPHIC 84130
10 GRAPHIC g103829ex99_1s14g1.jpg GRAPHIC 89646
11 GRAPHIC g103829ex99_1s15g1.jpg GRAPHIC 73496
12 GRAPHIC g103829ex99_1s16g1.jpg GRAPHIC 57315
13 GRAPHIC g103829ex99_1s17g1.jpg GRAPHIC 73914
14 GRAPHIC g103829ex99_1s18g1.jpg GRAPHIC 117951
15 GRAPHIC g103829ex99_1s19g1.jpg GRAPHIC 77988
16 GRAPHIC g103829ex99_1s1g1.jpg GRAPHIC 49942
17 GRAPHIC g103829ex99_1s20g1.jpg GRAPHIC 116299
18 GRAPHIC g103829ex99_1s21g1.jpg GRAPHIC 84955
19 GRAPHIC g103829ex99_1s22g1.jpg GRAPHIC 86508
20 GRAPHIC g103829ex99_1s23g1.jpg GRAPHIC 66489
21 GRAPHIC g103829ex99_1s24g1.jpg GRAPHIC 75587
22 GRAPHIC g103829ex99_1s25g1.jpg GRAPHIC 94686
23 GRAPHIC g103829ex99_1s26g1.jpg GRAPHIC 79146
24 GRAPHIC g103829ex99_1s27g1.jpg GRAPHIC 101259
25 GRAPHIC g103829ex99_1s28g1.jpg GRAPHIC 87701
26 GRAPHIC g103829ex99_1s29g1.jpg GRAPHIC 86623
27 GRAPHIC g103829ex99_1s2g1.jpg GRAPHIC 133575
28 GRAPHIC g103829ex99_1s30g1.jpg GRAPHIC 57537
29 GRAPHIC g103829ex99_1s31g1.jpg GRAPHIC 76081
30 GRAPHIC g103829ex99_1s32g1.jpg GRAPHIC 74033
31 GRAPHIC g103829ex99_1s33g1.jpg GRAPHIC 67778
32 GRAPHIC g103829ex99_1s34g1.jpg GRAPHIC 72409
33 GRAPHIC g103829ex99_1s35g1.jpg GRAPHIC 64284
34 GRAPHIC g103829ex99_1s36g1.jpg GRAPHIC 76629
35 GRAPHIC g103829ex99_1s37g1.jpg GRAPHIC 85069
36 GRAPHIC g103829ex99_1s38g1.jpg GRAPHIC 89649
37 GRAPHIC g103829ex99_1s39g1.jpg GRAPHIC 70907
38 GRAPHIC g103829ex99_1s3g1.jpg GRAPHIC 76327
39 GRAPHIC g103829ex99_1s40g1.jpg GRAPHIC 112996
40 GRAPHIC g103829ex99_1s41g1.jpg GRAPHIC 81521
41 GRAPHIC g103829ex99_1s42g1.jpg GRAPHIC 69166
42 GRAPHIC g103829ex99_1s43g1.jpg GRAPHIC 80549
43 GRAPHIC g103829ex99_1s44g1.jpg GRAPHIC 57728
44 GRAPHIC g103829ex99_1s45g1.jpg GRAPHIC 36687
45 GRAPHIC g103829ex99_1s46g1.jpg GRAPHIC 64125
46 GRAPHIC g103829ex99_1s47g1.jpg GRAPHIC 15845
47 GRAPHIC g103829ex99_1s48g1.jpg GRAPHIC 96156
48 GRAPHIC g103829ex99_1s49g1.jpg GRAPHIC 104281
49 GRAPHIC g103829ex99_1s4g1.jpg GRAPHIC 43915
50 GRAPHIC g103829ex99_1s50g1.jpg GRAPHIC 90238
51 GRAPHIC g103829ex99_1s51g1.jpg GRAPHIC 94507
52 GRAPHIC g103829ex99_1s52g1.jpg GRAPHIC 83529
53 GRAPHIC g103829ex99_1s53g1.jpg GRAPHIC 65903
54 GRAPHIC g103829ex99_1s54g1.jpg GRAPHIC 72419
55 GRAPHIC g103829ex99_1s55g1.jpg GRAPHIC 83426
56 GRAPHIC g103829ex99_1s56g1.jpg GRAPHIC 87422
57 GRAPHIC g103829ex99_1s57g1.jpg GRAPHIC 85402
58 GRAPHIC g103829ex99_1s58g1.jpg GRAPHIC 63377
59 GRAPHIC g103829ex99_1s59g1.jpg GRAPHIC 95991
60 GRAPHIC g103829ex99_1s5g1.jpg GRAPHIC 77558
61 GRAPHIC g103829ex99_1s60g1.jpg GRAPHIC 58747
62 GRAPHIC g103829ex99_1s6g1.jpg GRAPHIC 73454
63 GRAPHIC g103829ex99_1s7g1.jpg GRAPHIC 83944
64 GRAPHIC g103829ex99_1s8g1.jpg GRAPHIC 70763
65 GRAPHIC g103829ex99_1s9g1.jpg GRAPHIC 82349
  Complete submission text file 0001193125-24-003885.txt   6760172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acrv-20240108.xsd EX-101.SCH 2837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrv-20240108_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrv-20240108_pre.xml EX-101.PRE 11698
67 EXTRACTED XBRL INSTANCE DOCUMENT d103829d8k_htm.xml XML 3459
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41551 | Film No.: 24518335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)